Robust Causal Inference of Drug-drug Interactions
药物相互作用的稳健因果推断AI 解读 ↓
← 返回论文列表与筛选
阅读说明
本页整理公开书目信息，不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成，未完成全文核验，可能有误；具体假设、证明与结论请核对原文。摘要保留来源文本，未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要；缺少可靠材料时保留待补状态。
本页为预印本版本；arXiv 收录、作者填写的期刊信息以及作者既有发表经历，都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对，只展示已核实例，档案仍可能误合并。
引用量采用 OpenAlex 单条关联记录，不合计多个记录；关联记录可能包含正式发表版本，不等于此版本单独引用。缺失不视为零，引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配，同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列，再参考通用方法与发表日期。
分类依据与纠错
AI 根据所提供的论文材料归类：摘要研究多值处理下药物相互作用的因果效应及混杂调整方法。
反馈分类问题
正在核对关联版本…
代码、数据与补充材料
正在核对对应版本的资源…
药物相互作用的稳健因果推断
- 研究问题
- 如何估计药物 B 的存在相对于不存在时对药物 A 因果效应的改变，并降低倾向得分模型误设对药物相互作用估计的影响？
- 方法与思路
- 作者提出两种经验似然加权方法，允许指定多个倾向得分模型；第二种还加入非参数约束，直接平衡用户指定的协变量。
- 材料陈述的贡献
- 摘要称，候选倾向得分模型中至少一个正确时，两种估计量具有一致性；模拟报告相对标准 IPTW 的稳健性和效率改善。
- 阅读关注点
- 应核对相互作用效应的尺度、识别条件、多个模型对应的约束和权重可行性，并检查模拟设定及电子病历应用中的混杂控制。
- 阅读边界
- 这是 arXiv 预印本，同行评审或期刊接收未经核实。多重稳健性依赖候选模型含正确模型，摘要未说明完整条件及性能改善的范围。
原文摘要
There is growing interest in developing causal inference methods for multi-valued treatments with a focus on pairwise average treatment effects. Here we focus on a clinically important, yet less-studied estimand: causal drug-drug interactions (DDIs), which quantifies the degree to which the causal effect of drug A is altered by the presence versus the absence of drug B. Confounding adjustment when studying the effects of DDIs can be accomplished via inverse probability of treatment weighting (IPTW), a standard approach originally developed for binary treatments and later generalized to multi-valued treatments. However, this approach generally results in biased results when the propensity score model is misspecified. Motivated by the need for more robust techniques, we propose two empirical likelihood-based weighting approaches that allow for specifying a set of propensity score models, with the second method balancing user-specified covariates directly, by incorporating additional, nonparametric constraints. The resulting estimators from both methods are consistent when the postulated set of propensity score models contains a correct one; this property has been termed multiple robustness. We then evaluate their finite sample performance through simulation. The results demonstrate that the proposed estimators outperform the standard IPTW method in terms of both robustness and efficiency. Finally, we apply the proposed methods to evaluate the impact of renin-angiotensin system inhibitors (RAS-I) on the comparative nephrotoxicity of nonsteroidal anti-inflammatory drugs (NSAID) and opioids, using data derived from electronic medical records from a large multi-hospital health system.